Anavex Life Sciences Corporation
NASDAQ:AVXL 1:31:44 PM EDT
Anavex Life Sciences Corporation Stock, NASDAQ:AVXL
630 5th Avenue, 20th floor, New York, New York 10111
United States of America
Phone: +1.844.689.3939
Number of Employees: 40
Description
Anavex Life Sciences Corp. is a clinical stage biopharmaceutical company, which engages in the development of different therapeutics for the treatment of neurodegenerative and neurodevelopmental diseases. Its lead compound, ANAVEX2-73, is being developed to treat Alzheimer's and Parkinson's disease and central nervous system diseases, including Rett syndrome. The company was founded by Harvey Lalach and Athanasios Skarpelos on January 23, 2004 and is headquartered in New York, NY.